Chapter 42: Antihypertensive Drugs & Blood Pressure Control

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Hello and welcome back to the Deep Dive.

Today we are strapping in for something a little different, a little more intense,

and honestly incredibly useful.

We're calling this one the Last Minute Lecture Series.

That's right, and we know exactly who you are.

Yeah, you're likely a nursing student, it's probably late, you have a massive pharmacology exam tomorrow,

and you're staring at a textbook that feels like it weighs more than your car.

Or maybe you're just a curious learner who wants to understand how the medical world manages one of the most common killers on the planet without wading through a thousand pages of dense medical jargon yourself.

Either way, you're in the right place.

Exactly.

So our mission today is very specific.

We're doing a deep dive summary of chapter 42 anti -hypertensives from the text pharmacology,

a patient -centered nursing process approach, the 12th edition.

And we are going to squeeze every single ounce of value out of this chapter for you.

Now because this is a last minute lecture format, we have some really strict rules of engagement to keep us focused and frankly accurate.

Right, we are sticking strictly to the text.

I'm not bringing in outside anecdotes about my cousin's blood pressure regimen, and we aren't diving into experimental treatments that aren't in the book.

If it's not in chapter 42, it's not in this deep dive.

Not at all.

And we're following the chapter's exact order, that's a really important point.

We want to mirror your reading experience so you can literally follow along in the book if you want.

We're going to unpack the physiology, the guidelines, and the big seven, yes, seven major categories of drugs used to treat high blood pressure.

It sounds like mountain to climb, I know.

But we're going to break it down so it actually sticks in your brain.

We aren't just reading a list, we're connecting the dots between how the body works and how these drugs essentially hack that system.

So let's start at the very top, chapter 42.

What is the what here?

We're talking about hypertension.

Why does the book start with such a heavy focus on this one condition?

Is it really that big of a deal?

Oh, it is the biggest deal.

I mean, the text doesn't mince words here at all.

It defines hypertension as the most common condition leading to myocardial infarction.

That's a heart attack.

A heart attack, right.

Stroke, renal failure, and death.

It's pretty much the gateway to every cardiovascular disaster you can think of.

And it's called the silent killer for a reason, right?

Exactly, because you don't necessarily feel it happening, you don't walk around feeling pressurized, you know.

The damage is being done silently inside your arteries until it's often too late.

Right, okay.

So the text distinguishes between two main types right out of the gate.

First up, we have essential hypertension.

Right, and despite the name, it is definitely not essential to have.

Essential in medical speak here basically means idiopathic or primary.

Meaning we don't really know the cause.

We don't know the single cause, and this type, essential hypertension, accounts for a staggering 90 to 95 percent of all cases.

Wow, that is a huge majority.

It is.

The text is very honest here.

It says the exact origin is unknown.

We don't have a single virus or a specific bacteria to blame.

But it's linked to other factors.

It's not just bad luck.

Not at all.

It is heavily, heavily linked to contributing factors.

We're talking about things like hyperlipidemia, a diet high in saturated fats and salt, being physically inactive, chronic stress, excessive alcohol, and smoking.

So it's basically a checklist of modern living.

Unfortunately, in many ways, yes.

And the stats on obesity in the text are pretty staggering.

It says approximately 65 percent of female and 78 percent of male hypertension cases can be attributed to obesity.

That's a massive correlation.

It's huge.

It suggests that for many people, just the physical mass of the body is forcing the heart to work that much harder to push fluid through a much larger system.

Okay, so that's the vast majority of cases.

What's the other type?

Secondary hypertension.

This is the minority, only about 5 to 10 percent of cases.

This is where the high blood pressure is directly related to another medical condition, like a renal or endocrine disorder.

So it's secondary to another problem.

Exactly.

If you fix the kidney issue or you fix the hormonal imbalance,

the blood pressure often resolves on its own.

But for today, we are mostly battling that 90 percent beast essential hypertension.

Okay, so we know what it is.

How do we measure it?

The text references the JNC 8 guidelines from 2017.

If you are a student, these numbers are likely your bread and butter.

Oh, absolutely.

This is prime exam material.

And almost certainly a multiple choice question on your test.

You need to know them cold.

The whole goal of these guidelines is specifically to decrease the risk of cardiovascular disease or CVD.

So let's break down the numbers.

What's considered normal?

Normal blood pressure is defined as less than 120 over 80 millimeters of mercury.

Can we pause for just a second on that?

I always see these numbers, you know, 120 over 80.

What is physically happening in the arteries during those two numbers?

That's a fantastic question.

The top number systolic is the pressure in your arteries when the heart is contracting, when it's actively squeezing blood out.

It's the max pressure in the system.

Okay, the peak force.

Right.

And the bottom number diastolic is the pressure in the arteries when the heart is relaxing and refilling between beats.

It's the resting pressure.

So if that bottom number, the diastolic, is high, that means your arteries are under a lot of pressure even when your heart is supposed to be resting.

Precisely.

And that is why a high diastolic number is so dangerous.

It means the entire cardiovascular system never gets a break.

It's under constant strain.

That makes so much sense.

Okay, so normal is under 1280.

Then we get into the elevated zone.

Elevated is defined as a systolic pressure between 120 and 129 and a diastolic of less than 80.

Note the and there.

Yes, that's key.

The bottom number is still okay, but that top number, the systolic, is starting to creep up.

It's a warning sign.

And then we hit stage one hypertension.

Stage one falls in the range of 130 over 80 to 139 over 89.

Now we're officially in hypertensive territory.

This is where we start getting concerned and talking about interventions.

And stage two.

Stage two hypertension is anything 140 over 90 or greater.

This is the danger zone, where the risk for stroke and heart attack really starts to climb.

Now treating this isn't just about getting everyone on the planet to 120 over 80, is it?

The text mentions age is a major factor in the treatment goals.

Correct.

This is where real clinical judgment comes into play.

According to the JNC8 guidelines, for the general population under 60 years old, the treatment goal is to get their blood pressure under 140 over 90.

Okay.

But for older adults?

If the patient is over 60 years old, the target is actually a bit more lenient.

The goal is less than 150 over 90.

That seems counterintuitive.

Why the leniency for older adults?

Shouldn't we be more careful with them?

We are being careful, but we're being careful about a different kind of risk.

If you drop an older person's blood pressure too aggressively, they could get dizzy and fall.

Exactly.

You risk orthostatic hypotension, where they get lightheaded, faint, and fall.

Or you risk not getting enough blood flow, enough perfusion to their brain or kidneys.

So the guidelines accept a slightly higher number to ensure safety from falls and hypoperfusion.

Ah, so you're balancing the long -term stroke risk against the immediate fall risk.

That's the art of medicine right there.

It's a balancing act.

Okay.

So before we start throwing drugs at the problem, we need to understand the physiologic regulators.

How does the body control blood pressure naturally?

Because when we give these medications, we're essentially hacking these very systems.

You've hit the nail on the head.

To understand the drugs, you have to understand the body's plumbing.

The text highlights a few key players, but the biggest one you need to understand for pharmacology, and frankly for passing your class, is the relationship between the kidneys and the RAS.

R -A -A -S, the renin -angiotensin -aldosterone system.

Let's unpack this because figure 42 .1 in the text makes a huge deal about it, and almost every drug class we discuss later on touches this system in some way.

It is the absolute foundation.

I like to think of the R -A -A -S as a survival mechanism from when we were cavemen.

Back then, salt and water were scarce.

Dying of dehydration or bleeding out was a very real risk.

So the body built a system to hold on to water at all costs.

To hoard water and salt at all costs.

Yeah.

But now we live in a world of potato chips and unlimited tap water.

Right.

We have an evolutionary mismatch.

We really do.

So here's the flow, and it's a cascade.

The kidneys are constantly monitoring fluid volume and pressure.

When blood pressure decreases, or when the kidneys just think it's decreased, they release an enzyme called renin.

Okay, renin is the trigger.

Renin is the first domino.

Renin then floats around and stimulates the production of a substance called angiotensin the first.

And angiotensin the first, is it a big deal on its own?

Not really.

The text points out it's a pretty weak vasoconstructor.

It's just the precursor.

But then an enzyme called ACE angiotensin converting enzyme finds an angiotensin the first and converts it into angiotensin the second.

And angiotensin the second is the bad guy in the story.

It is the supervillain.

It is an extremely potent vasoconstrictor.

It clamps down on blood vessels immediately.

So imagine taking a garden hose and just squeezing it as tight as you can.

The pressure inside skyrockets.

Precisely.

But angiotensin the second doesn't stop there.

It's a double threat.

It also travels to the adrenal glands and triggers the release of another hormone aldosterone.

Right.

And aldosterone causes sodium retention?

Yes.

And in the body, there is a golden rule of physics where sodium goes.

Water follows.

Always.

So you retain sodium, you retain water, your overall fluid volume increases, and your blood pressure goes up.

Because there's simply more liquid in the pipes.

It's a genius system for survival if you're dehydrated in the desert.

But a complete disaster if you're trying to manage chronic hypertension.

A total disaster.

Okay.

So that's the RAAS.

The text also mentions baroreceptors.

What are they?

These are your body's pressure sensors.

They're located in the aorta and the carotid sinus.

They're like little pressure gauges constantly monitoring the situation.

And what do they do with that information?

They send signals directly to the vasomotor center in the medulla of the brain.

If they sense pressure is falling,

the brain instantly releases catecholamines.

Like adrenaline?

Exactly.

Norepinephrine and epinephrine.

These hormones constrict vessels and jack up the pressure almost instantaneously.

The baroreceptors are the body's rapid response team.

And there are other hormones too.

I see ADH mentioned.

Right.

Antidiuretic hormone.

It's produced by the hypothalamus and released by the pituitary gland.

The name really tells you everything it does.

Antidiuretic.

It stops you from peeing.

So it conserves water.

It stimulates the kidneys to conserve and retain water, especially when there's a fluid volume deficit.

More water in the system equals higher blood pressure.

Okay.

So we have the plumbing laid out.

We have the hormonal hoarding of water with RAAS and ADH.

And we have the nervous system squeezing the pipes with the baroreceptors.

This is complex.

It is, but it's elegant.

And every part of it is a potential target for our drugs.

That makes sense.

Before we get to the drugs, though, the text has a very specific section on cultural responses and older adults.

This seems really important for that patient -centered part of the book's title.

It is absolutely crucial.

Pharmacology is not one size fits all.

You cannot just memorize drug X treats hypertension and apply it to every single person blindly.

So what are the key differences the chapter highlights?

Well, it explicitly states that African American patients are more likely to develop hypertension at an earlier age and have a higher mortality rate from it than the white population.

But more importantly, physiologically, there's often a difference in how that hypertension works.

It mentions something called low renin hypertension.

Yes, exactly.

The text notes that African American patients are particularly susceptible to low renin hypertension.

This means their high blood pressure isn't primarily being driven by an overactive RAAS system that's churning out a lot of renin.

So if you give them a drug that's designed to stop it's not going to work very well, is it?

Because they have less renin circulating to begin with, drugs that specifically target that pathway like beta blockers and ACE inhibitors are less effective as monotherapy.

What does monotherapy mean here?

It means when the drug is used all by itself, you're basically attacking a pathway that isn't the main source of the problem for that patient.

That is a vital clinical pearl.

So what does the text say does work for this demographic?

The text says the most effective drugs for African American patients are alpha -1 blockers, calcium channel blockers, and diuretics.

These drugs work on the vessels and fluid volume more directly, kind of bypassing that renin issue.

So you're not trying to fix a problem that isn't there.

Exactly.

However, the text does add an important note.

If you combine a beta blocker or an ACE inhibitor with a diuretic, the efficacy improves significantly.

The diuretic handles the volume, which then makes the other drug more effective.

Okay.

What about Asian American patients?

The book points out that they tend to be twice as sensitive to beta blockers and other antihypertensives compared to white patients.

Their metabolism just handles the drugs differently.

So what's the clinical implication of that?

It means a reduction in dosing is frequently needed.

If you give a standard dose, you might accidentally crash their blood pressure.

You have to start low and go slow.

And Native American patients?

The text says they show a reduced response to beta blockers compared to white patients.

So again, the takeaway here is that you must know your patient's background because it fundamentally changes the chemistry and how you approach treatment.

Let's shift to older adults.

The text says 65 % of people over 55 have hypertension.

I mean, it's nearly two in three people.

It's incredibly common.

So what is the major safety risk here when we start treating them with these powerful drugs?

In big, bold, slashing letters.

Orthostatic hypotension, also known as postural hypotension.

That's the classic head rush when you stand up too fast and the room spins.

That's the one.

Let's look at the mechanism.

In a young, healthy person, when you stand up, gravity immediately pulls blood down to your feet.

Your baroreceptors instantly sense that drop in pressure to the brain and tell your leg vessels to clamp down, shooting blood right back up to your head.

It's instantaneous.

Like a reflex.

A very fast reflex.

In older adults, that sympathetic nervous system response can be sluggish.

It's like a lagging internet connection.

So they stand up, the blood pools in their feet, the brain doesn't get enough oxygen.

And down they go.

If you add antihypertensive drugs on top of that, drugs specifically designed to lower their pressure and relax their vessels, the risk of a fall is huge.

And a fall in an older adult can be catastrophic.

It can be.

We're talking hip fractures, head bleeds.

It's a major cause of morbidity and mortality.

So the key nursing instruction is?

Teach them to change positions gradually.

Don't jump out of bed like a teenager.

The instruction is to sit on the edge of the bed first, dangle their legs for a minute, maybe count to 10, and then stand up slowly.

The text also really emphasizes lifestyle modification here, like sodium restriction to 2 ,400 milligrams a day.

Okay, this is all fantastic background.

Let's move into the treatment strategies themselves.

Section three covers non -pharmacologic control.

This is the first line of defense, right?

It absolutely should be.

Before we even think about a prescription pad, we need to look at lifestyle, stress reduction, regular exercise, salt restriction, and smoking cessation.

And how effective are these really?

They can be incredibly effective, especially for elevated or stage one hypertension.

But the text gives a pretty clear rule of thumb.

If the systolic pressure is consistently greater than a 140, drugs are generally ordered alongside these methods.

So you can't usually exercise your way out of stage two hypertension without some help.

It's very difficult.

Yeah.

But the lifestyle changes make the medications work better and can help you use a lower dose.

Let's talk about exercise for a second.

How does running on a treadmill actually help the body's plumbing?

Over time, consistent aerobic exercise decreases systemic vascular resistance.

It basically makes your blood vessels more flexible and compliant, less stiff and rigid.

So the pipes are less brittle.

That's a great way to put it.

And stress reduction lowers those circulating catecholamines, the epinephrine and norepinephrine, that are constantly squeezing your vessels and keeping you in that low -grade fight or flight state.

And when we do need that pharmaceutical help, the text outlines seven major categories of drugs.

We are going to go through them one by one.

Right.

And the general approach, as the book emphasizes, is start low and go slow.

You always use the lowest effective dose.

Why is that?

To minimize side effects.

Often, providers will use combination therapy.

Instead of giving a massive dose of one drug that causes a ton of side effects, they'll give small doses of two different drugs that attack the pressure from different angles.

It's more effective and better tolerated.

All right.

Let's dive into the drug classes.

Category one, diuretics.

The text says these are effective as first -line drugs for mild hypertension.

They are.

Conceptually, you can think of this as lowering the pressure in a water balloon by letting some of the water out.

Simple enough.

They promote sodium depletion.

And since we know water follows sodium, you end up peeing out that extra fluid.

This decreases your extracellular fluid volume.

Less fluid in the pipes means less pressure on the walls.

Okay.

The text highlights two main types here that we really need to distinguish.

First, the thiazides.

Hydrochlorothiazide, or HCPZ, is the superstar here.

It is the most frequently prescribed diuretic for mild hypertension.

It works on a specific part of the kidney called the distal convoluted tubule that's toward the far end of the kidney's filtering system.

But there's a huge but here, a major contraindication.

Yes.

The text is very clear.

It's not recommended for patients with renal insufficiency.

How do we as nurses know if a patient has renal insufficiency?

We look at the labs, specifically the creatinine clearance.

If the creatinine clearance is less than 30 milliliters per minute, thiazides basically stop working.

Their kidneys are too weak for the drug to be effective.

So in that case, what do we use instead?

We move to the more powerful option.

Loop diuretics, like furosemide.

These work on a different part of the kidney, the loop of henla.

And they're stronger.

Much stronger.

They're like a fire hose compared to a garden hose.

They don't depress renal blood flow as much, so they still work well even in patients with kidney issues.

But there's a downside.

There is.

The book notes they aren't usually for RAAS -based hypertension because, ironically, dropping the fluid volume that fast can actually cause a spike in serum renin levels.

The body panics and tries to hold on to the fluid it has left.

And with diuretics, we have to talk about potassium.

This is a classic nursing exam topic.

Always.

You will be tested on this.

Thiazides and loop diuretics are generally potassium -wasting.

You lose potassium in the urine right along with the sodium in water.

Why is that a big deal?

Potassium is absolutely essential for your heart's electrical rhythm.

If your potassium level drops too low a condition called hypokalemia, you can have fatal arrhythmias.

So how do we manage that?

Well, you'll often see combinations, which are listed in box 42 .1 in the text.

A potassium -wasting thiazide might be paired with a potassium -sparing diuretic.

Or it might be paired with an ACE inhibitor.

Why an ACE inhibitor?

Because ACE inhibitors tend to make the body hold on to potassium, so they balance out the loss from the thiazide.

It's a very clever chemical balancing act to keep potassium levels stable.

Okay, that's a great overview of diuretics.

Let's move on to category two.

Sympatholitics.

This sounds like a sci -fi villain group.

It does, doesn't it?

But it just means sympathetic depressants.

Litic means to cut or destroy.

So these drugs work by cutting the sympathetic nervous system response.

They stop that fight -or -flight reaction that jacks up blood pressure?

Exactly.

They tell the body to calm down.

The text mentions five subgroups, but let's focus on the main ones discussed in detail.

And the big one, everyone knows.

Beta adrenergic blockers, or just beta blockers.

Yeah, yes, the lonal drugs.

Yeah.

Metaprolol, atenolol, propranolol.

To understand these, I like to use an engine analogy.

Your heart is an engine.

The sympathetic nervous system is the gas pedal.

Beta blockers put a governor on that engine.

They limit how fast it can rev.

So they literally reduce the heart's output.

Yes.

They reduce cardiac output.

They reduce vascular resistance.

They lower the heart rate.

They decrease contractility.

And they even reduce renin release from the kidneys.

They tell the heart and the vessels to just chill out.

Now we absolutely have to distinguish between non -selective and cardio -selective.

This seems like a vital safety point.

It is life or death for some patients.

You have two main types of beta receptors you need to know.

Beta 1 and beta 2.

What's the easy way to remember which is which?

The classic mnemonic is you have one heart, beta 1, and two lungs, beta 2.

One heart, two lungs.

Got it.

Non -selective beta blockers like propranolol and carvitolol are messy.

They're not picky.

They inhibit beta 1 in the heart, adj2 in the lungs.

And why is blocking beta 2 a problem?

Because normally stimulating your beta 2 receptors opens up your airways.

It causes bronchodilation so you can get more air during a fight or flight situation.

If you block beta 2, you cause the opposite.

Bronchoconstriction.

You tighten the airways.

So you would never give these to someone with breathing problems.

Absolutely not.

Non -selective beta blockers are contraindicated in patients with COPD or asthma.

You do not want to constrict the airways of someone who already struggles to breathe.

It's incredibly...

The text adds an important nuance.

Cardioselectivity is not absolute.

At high doses, even these selective drugs can start to spill over and affect the beta 2 receptors in the lungs.

So even with selective drugs, you still have to use caution in patients with pulmonary disease.

Let's look at the prototype drug chart for metaprol.

This is a very common drug.

What are the key highlights for a nursing student?

Okay, so it's used for hypertension, acute MI, angina, and heart failure.

But look closely at the contraindications.

Heart block, specifically second or third degree sinus bradycardia and cardiogenic shock.

Why those conditions?

Because the drug's whole job is to slow the heart down.

If you give it to a patient whose heart is already beating at, say, 40 beats per minute or isn't conducting electrical signals properly, like in heart block, you might stop their heart entirely.

You don't put a governor on an engine that's already barely idling.

That makes perfect sense.

And the common side effects.

Bradycardia, of course.

A slow heart rate, hypotension, low blood pressure, dizziness and fatigue are very common because the cardiac output is lower.

And interestingly, erectile dysfunction is listed as a significant side effect.

That's a huge deal for patient compliance.

It's massive.

If a male patient suddenly stops taking his meds and doesn't tell you, this is often the reason why.

As a nurse, you have to be able to have that sensitive conversation.

And I see a big box warning here in the text.

A very important one.

Do not abruptly discontinue beta blockers.

It can cause rebound hypertension,

angina, dysrhythmias, and even a myocardial infarction.

Why does that rebound happen?

Think of it like this.

You're holding a door shut against the howling wind for months.

That's the beta blocker holding back the body's adrenaline.

If you suddenly let go of that door handle, if you stop the drug cold, the wind is going to slam that door open with violent force.

The heart has become sensitized to the adrenaline.

And if you pull the breakaway suddenly, it accelerates dangerously.

So you have to taper them off slowly.

Over weeks, yes.

Never stop them abruptly.

The text also has a box on herbal interactions.

I love these because patients often don't think to mention herbal supplements.

They think they're natural and therefore totally safe.

It's such dangerous logic.

For example, the text mentions mahuang, which is ephedra.

It's a stimulant.

It directly counteracts beta blockers.

You're literally pressing the gas and the brake at the same time.

What else?

Black cohosh can increase the hypotensive effects.

So your blood pressure drops too low.

And hawthorn can actually increase the effects of beta blockers as well.

The nurse has to ask specifically, what teas, supplements, or herbal remedies are you taking?

So purely from a nursing process standpoint, what are our key actions for a patient on beta blockers?

Assessment is everything.

You must check vital signs, specifically the heart rate and blood pressure before every single administration.

If the pulse is low, usually under 60, you hold the drug and you call the provider.

You also check labs, BUN, kuatinin, AST, LDH as elevations are possible.

And for patient teaching.

Medical or bracelets are suggested.

You need to teach them how to take their own radial pulse at home.

And again, you teach them to rise slowly because of that risk of orthostatic hypotension.

Okay, that was an amazing deep dive into beta blockers.

Let's look at group two of the sympatholytics, centrally acting alpha -2 agonists.

Right.

These are drugs like clonidine, methyl dopa, and guanfacine.

These are interesting because they work directly in the brain stem.

How do they work?

They stimulate alpha -2 receptors.

Now, this is a little tricky.

Usually stimulation means more action, but stimulating these specific alpha -2 receptors provides negative feedback.

It's like it tells the brain, okay, hey, we have enough adrenaline circulating down here.

And the brain responds by decreasing sympathetic activity from the central nervous system.

So it basically hacks the feedback loop.

It does.

And the end result is vasodilation and a lower heart rate.

What are the main downsides of this class?

Drowsiness is a really big one because you are suppressing the central nervous system.

Dry mouth is also very common.

And they can cause sodium and water retention.

So they're very often paired with the diuretic to prevent edema and fluid overload.

And I see another warning here about stopping abruptly.

Yes, this is a theme.

Similar to beta blockers, you never ever abruptly stop clonidine.

It can cause a severe rebound hypertensive crisis.

We're talking restlessness, tremors, headache, and a dangerously high tachycardia.

The text singles out methyl dopa for use in pregnancy.

It does.

It's one of the drugs that is frequently used for pregnancy -induced hypertension.

It's considered one of the safer options, though the text cautions that you have to monitor liver function.

And clonidine has a unique delivery method.

It does.

It's available as a seven -day transdermal patch.

This is fantastic for patient compliance because they just put it on once a week and forget about it.

Though skin irritation at the site can be an issue for some people.

Okay, moving on to group three, alpha adrenergic blockers.

These are your zozin drugs, prozozin, doxazosin, terezosin.

They work by blocking alpha receptors.

Now, alpha receptors are primarily responsible for the constriction of blood gussels.

So if you block them?

The vessels relax and dilate.

Pretty straightforward.

The text mentions a bonus benefit here, especially regarding lipids.

Right.

These are particularly useful for treating hypertension in patients who also have lipid abnormalities.

The chapter notes that they can decrease LDL, the bad cholesterol, and increase HDL, the good cholesterol.

Plus, they're safe for patients with diabetes because they don't affect glucose metabolism.

Let's look at the prototype drug,

prozozin.

Okay, so it has a high protein binding and a short half -life, which means it usually needs to be dosed two or three times a day.

But the big, big side effect to watch for is something called the first dose phenomenon.

Which is what, exactly?

Syncope, fainting.

It can cause a sudden, profound drop in blood pressure after that very first dose.

Can you paint the picture for us of what that looks like?

Sure.

The patient takes their first pill, maybe before bed.

They wake up at 2 a .m.

to use the bathroom.

They stand up.

Because their alpha receptors are blocked, their blood vessels are wide open and can't constrict.

Gravity pulls all the blood down to their feet instantly.

The brain gets no oxygen, and they hit the floor.

That's incredibly dangerous.

So what's the key teaching point?

The book stresses that the first dose should be taken at bedtime,

and the patient should be advised not to get up for a few hours.

Let the body adjust to this new state while they are safely lying down.

And it causes nasal congestion.

That seems random.

It's that vasodilation again.

It's not selective.

It widens blood vessels everywhere, and that includes the mucous membranes inside your nose.

Swollen blood vessels in the nose equals a stuffy nose.

Okay, quickly, group four.

Alpha -1 and beta -1 adrenergic blockers.

The main one mentioned here is libidolol.

It's a hybrid drug that does double duty.

It blocks alpha -1 receptors, which causes vasodilation, and it blocks beta -1 receptors to lower the heart rate.

A two -for -one deal.

But because it has that beta -blocking component, you have to remember that large doses can block beta -2 receptors.

So again, use with caution in patients with severe asthma.

That wraps up the sympathetic.

Let's move to section six.

Direct acting arterial or vasodilators.

Hydrolyzine and minoxidil are the main oral drugs here.

I like to think of these as the heavy artillery.

Why is that?

Because they don't mess around with receptors or hormones.

They act by relaxing the smooth muscles of the arteries directly.

It's a very direct, powerful effect that causes massive vasodilation and increases blood flow to the brain and kidneys.

But the text emphasizes that there's a reflex problem with these drugs.

Yes.

The body fights back, and it fights back hard.

When that powerful vasodilation causes the blood pressure to drop significantly, and suddenly the body's baroreceptors think you're hemorrhaging.

They think you're bleeding out.

So the panic alarm goes off.

The panic alarm goes off.

The body responds with two things.

Reflex tachycardia, the heart starts racing to try to compensate, and a massive release of renin from the kidneys.

So you fix the high pressure, but now the patient's heart is beating out of their chest.

Exactly.

It's a classic example of the body's compensatory mechanisms.

So how do we fix that?

We almost always prescribe these drugs with a beta -blocker to stop the tachycardia, and with a diuretic to stop the edema that comes from the fluid retention.

So you almost never see hydrolazine used alone.

Very, very rarely.

It's a team effort.

The chapter also mentions nitroproside here.

Nitroproside is for acute hypertensive emergencies only.

We're talking ICU -level care.

It's an extremely potent vasodilator that acts on both arterial and venous vessels.

But it comes with serious risks.

Very serious.

The book highlights the risk of cyanide toxicity and thiocyanate toxicity.

The drug literally breaks down into cyanide in the body.

And from a practical nursing standpoint.

The solution is incredibly sensitive to light.

If you expose it to light, it degrades and becomes ineffective.

The IV bag and tubing have to be protected from light, usually with an opaque covering like a brown bag or special foil.

And we have to mention minoxidil.

Isn't that also rugane?

It is indeed.

One of the main side effects listed for oral minoxidil is excess hair growth or hypertrichosis.

So yes, that side effect was cleverly repurposed and turned into a topical hair loss treatment.

It's a classic case of a bug becoming a feature.

All right.

Section seven.

This is a huge category in modern medicine.

A .C .E.

inhibitors.

Yes.

The PRILs.

Benazapril, Captopril, Enalapril, Lisnopril.

We talked about the RAAS earlier.

These drugs work by inhibiting A .C .E., the angiotensin -converting enzyme.

They stop the formation of that supervillain, angiotensin II.

And by blocking angiotensin II, they also block aldosterone release.

So the end result is?

You excrete sodium and water, which lowers your fluid volume.

But, and this is key, you retain potassium.

Who are these drugs less effective for?

We touched on this earlier.

Right.

As we mentioned, African -American patients and older adults often don't respond as well to A .C .E.

inhibitors when used as monotherapy, likely due to their lower renin levels.

But they work much better when combined with a diuretic.

And there is a major absolute contraindication here.

Pregnancy.

They can reduce placental blood flow and are known to cause harm to a developing fetus.

Absolutely contraindicated.

If a woman is of childbearing age, you need to be having conversations about effective birth control.

Let's talk about the side effects.

There is one that is famous or maybe infamous.

The A .C .E.

cough.

Yeah.

It's a constant, irritated, dry, non -productive cough.

Why on earth does a blood pressure pill cause a cough?

It's actually a fascinating bit of physiology.

A .C .E.

doesn't just manage blood pressure.

It also has another job, which is to break down a substance in the lungs called bradykin.

When you inhibit A .C .E., bradykin is no longer broken down effectively.

It builds up.

It builds up in the lungs and that buildup irritates the lung tissue and triggers the cough reflex.

It's incredibly annoying for patients and it's the primary reason people get switched off of these drugs.

And if they do have that cough, what do we usually switch them to?

To an ARB, which is the next category we'll get to in a second.

What are the other major side effects?

First dose hypotension is common.

Especially if they are already on diuretics and are a bit dehydrated.

Hyperkalemia, too much potassium, is a big one to watch for since the kidneys are retaining it.

And then there's the scary one, angioedema.

What exactly is that?

This is a severe hypersensitivity reaction.

It causes swelling of the face, tongue, lips, mucous membranes, and larynx.

It's rare, but it is medical emergency because it can completely block the airway.

And the text points out a higher risk in a certain demographic.

Yes, it notes a higher incidence in African -American patients.

It can happen within hours of the first dose or even a week later.

If your patient ever calls and says, My tongue feels thick, that is a 911 emergency.

Administration -wise, Moxapril is a bit of a diva.

Just a little bit.

The text says Moxapril requires an empty stomach for maximum effectiveness.

The others are generally okay to take with food.

And Captapril has a strange side effect.

It can diminish taste perception for the first month.

Patients might complain that their food tastes bland or metallic.

Okay, that was thorough.

Let's move to Section 8.

AERBs, angiotensin the sector receptor blockers.

These are the sardines.

Losartan, Valsartan, Omosartan.

They also work on the RAAS.

But there's a really important distinction.

What's the difference?

Instead of stopping the formation of angiotensin the second like the ACE inhibitors do, AERBs let the body make angiotensin the second, but they block it from binding to its receptors.

Specifically the AT1 receptors.

It's like putting tape over the keyhole.

That's a perfect analogy.

The key, which is angiotensin the second, is there, but it can't get into the log to cause vasoconstriction.

And what's the big advantage of this different mechanism?

No cough.

Because they don't inhibit the ACE enzyme, they don't cause that buildup of bradykinin in the lungs.

That is the key clinical difference and why we switch patients from an ACE to an ARB.

Let's look at the prototype drug from the text.

It's used for both hypertension and heart failure.

It's highly protein -bound, which is about 95 percent.

And just like ACE inhibitors, it's contraindicated in pregnancy, specifically the second and third trimesters.

And the adverse reactions.

Orthostatic hypotension, hyperkalemia again, you're always watching that potassium, and rarely rhabdomyolysis or renal dysfunction.

And I see another patient safety note here.

Do not confuse.

Yes, this is a classic look -alike sound -alike issue.

Do not confuse diavon, which is the brand name for valsartan, with diavol, which is estradiol.

One is for blood pressure.

The other is an estrogen hormone.

A mix -up could be catastrophic.

Checking the spelling is critical.

Section 9 is a brief one.

Direct renin inhibitors.

Right.

The main drug here is aliskarin.

It works even earlier in the RAAS cascade.

It binds with renin itself, preventing it from starting the whole process.

This causes a reduction in angiotensin first, angiotensin the second, and aldosterone.

So it cuts the RAAS off right at the source.

Exactly.

It's for mild to moderate hypertension.

But again, the text notes that it is not as effective as monotherapy in African -American populations.

Okay, last but not least, section 10, calcium channel blockers or CCBs.

These work by blocking the slow calcium channels in the myocardium, that's the heart muscle, and in the vascular smooth muscle of the arteries.

Explain the connection between calcium and muscles.

Muscles need calcium to contract.

You can think of calcium as the spark plug that ignites the contraction.

If you block the calcium from getting into the cell, the muscle cannot contract as forcefully.

So what's the result?

In the arteries, the smooth muscle relaxes, which leads to vasodilation.

And in the heart, the force of contraction is reduced, which lowers the heart's workload.

The text groups them into three distinct types.

Yes.

First, you have the phenylalkylamins, like verapamil.

It's used for chronic HTN, angina, and dysrhythmias.

Second, the benzothiazepines, like diltiasm.

And third, the largest group, the dehydropyridines.

These are your betapine drugs, like amylidapine and the sfidapine.

There's a very serious warning about myfidapine in the chapter that sounds life or death.

It is.

The text is extremely clear on this.

Immediate -release nifidapine, the 10 or 20 milligram liquid -filled capsules, has been associated with an increased incidence of profound hypotension, MI, and even death, especially in older adults.

Why is the immediate -release form so dangerous?

Because it drops the blood pressure way too fast.

If the pressure plummets that quickly, the vital organs, like the heart and brain, can go into shock from the lack of blood flow.

Therefore, the text states that only extended release preparations of nifidapine are recommended for treating chronic hypertension.

Let's look at the prototype for this class, amlodipine.

Amlodipine is very, very common.

It has a very long half -life, about 30 to 50 hours, which makes it excellent for once daily dosing and great for compliance.

And the main side effects?

Corriferal edema is the big one, swollen ankles.

And it's important to understand this isn't fluid retention from the kidneys, like with other drugs.

It's because the arterioles are so relaxed and dilated that fluid starts to leak out into the surrounding tissues.

Flushing, dizziness, and headache are also common.

And we have a food rule here, probably the most famous food -drug interaction rule in all of

The grapefruit juice rule.

You must avoid grapefruit and grapefruit juice with several CCBs, including verapamil, diltiasm, and nifidapine.

Why is that?

Grapefruit juice contains compounds that inhibit an enzyme in the liver, called CYP450.

This enzyme is responsible for breaking down the drug.

If you inhibit the enzyme, the drug doesn't get metabolized, and it builds up to potentially toxic levels in the blood.

So it significantly increases the drug levels.

It can lead to severe hypotension and other signs of toxicity.

And what about demographics for this class?

The text notes that calcium channel blockers tend to lower blood pressure more effectively in African American patients than drugs in many other categories, making them a very frequent first or second line choice for this population.

Wow.

Okay, that is the full pharmacological arsenal from Chapter 42.

It's a ton of information, but when you break it down by mechanism of action, it really does start to make sense.

It does.

It all comes back to the same basic principles of plumbing.

You're either relaxing the vessels, reducing the fluid volume, or slowing down the pump.

To wrap this all up, let's summarize the absolute key takeaways for the listener.

Give us the last minute lecture cheat sheet.

Okay.

Remember your ABCs of antihypertensives.

Alpha and beta blockers, ACEs and ARBs, calcium channel blockers, and diuretics.

Remember safety.

Orthostatic hypotension is a risk across the board, especially for older adults.

Slow transitions prevent falls.

What else?

You have to monitor potassium levels, thiazides and loops drop it, ACEs and ARBs raise it, and the big one, never ever stop these drugs abruptly due to the risk of rebound hypertension.

And the final thought to leave our listeners with.

The book is titled A Patient -Centered Nursing Process Approach.

And that's the whole game.

You have to match the drug to the patient, to their age, to their ethnicity, to their comorbidities like asthma or diabetes.

Treating the number on the blood pressure cuff isn't enough.

You have to treat the whole person attached to that arm cuff.

That is the mission.

This has been the last minute lecture on Chapter 42.

Good luck on that exam or just enjoy your newfound knowledge.

You've got this.

Thanks for listening to the Deep Dive.

Goodbye.

We'll see you next time.